Domestic medical equipment, foreign investors can shake it?

Pharmaceutical Network November 30 report pointed out in the nineteenth Congress that the main contradictions in our society have been transformed into the people's growing needs for a better life and uneven development of the imbalance between the major contradictions in our society is the overall relationship between the changes Historical changes are also instructive in the field of medical devices.

Medical devices and human life and health are closely related, and its level of development is directly related to the ability to meet the people's needs for a healthy life.

Medical Devices and drug As the two major supporting conditions for the implementation of hospital diagnosis and treatment, the characteristics of their industries and the role played by the hospitals are very similar, accounting for a large proportion of the medical revenue. As the medical devices are more cross-linked than the pharmaceutical professionals, Large, so the relevant state regulatory policy 'after the first drug supplies' is already an unwritten rule.

Medical device industry as medicine System supply-side reform an important part of the country attaches great importance to its healthy development. medical instruments The scientific deployment and rational use of health care have become the focus of comprehensive medical reform.

According to the "2016 China Medical Device Industry Development Blue Book," the total size of the domestic medical device market in 2016 will be about 370 billion yuan, an increase of 20.1% over 2015. Although the growth rate of China's medical device market is significantly higher than that of the global industry by about 5%, our country Instrument / drug market scale ratio of only 0.2: 1, well below the 0.5: 1 level in the global market, but also has great room for development.

According to the State Food and Drug Administration statistics, as of the end of 2016, China's medical device production enterprise Has reached 15,300, capable of producing CT, magnetic resonance, linear accelerator and other 43 categories, more than 300 sub-categories, tens of thousands of articles of medical equipment.

MedtechInsight released the top 100 global medical device company TOP100 in 2016. In terms of sales revenue, Medtronic, the No. 1 global Medtronic company in the world, achieved a sales volume of US $ 28.83 billion in 2016, ranking first in China Enterprise Xinhua medical sales of only 83.64 billion yuan, a difference of about 23 times.

The development of medical devices is greatly influenced by the development level of basic industries in the corresponding countries. The United States, Europe and Japan have long been the world's leaders or monopolies in the field of medical devices, and even the share of imported devices in some professional medical fields has even exceeded 80%.

China's medical device industry there are still unbalanced industrial layout, R & D investment deficiencies, innovation is not enough and other issues.

It can be seen that although the rapid development of medical device market in our country has great potential for development, the development of this industry is extremely unbalanced and the market competitiveness of national brands still needs to be improved.In recent years, China's medical device industry has introduced a series of reform measures, Designed to promote the healthy and rapid development of the medical device industry.

In October 2017, the State Council issued the Opinions on Deepening the Innovation of Examination, Approval and Approval System to Encourage the Innovation of Medicines and Medical Devices, put forward 36 reform measures. The most prominent policy direction is to encourage domestic substitution of imported brands and effectively enhance the market competition of national brands force.

Although the gap between domestic brands and imported products is shrinking in terms of technical level and innovation ability, many problems in the circulation and purchase and sale of medical devices have severely restricted the scientific allocation and rational use of domestic medical devices.

The main manifestations include: Imported brand products rely on monopoly status, taking the opportunity to suppress or acquire domestic brands; Medical device circulation more competition in the market environment; medical institutions for domestic brands is not enough trust, or even specify the purchase of imported products.

To 'put' equipment, for example, as China in vitro diagnostic, hemodialysis and other fields started late, import manufacturers provide free equipment for hospital Use, the hospital supplies its consumables (reagents), to seek later economic benefits, long occupied the medical market.

Equipment 'put' on the surface for the hospital to save costs, in fact to avoid the open bidding, a serious violation of the development of national brands.

In recent years, the medical device related laws and regulations are constantly revised and perfected, which has played a positive role in pushing forward the solution to the problems of the industry.

In July 2017, the Joint Commission of the People's Republic of China (PRC) and the nine ministries and commissions jointly issued the Program for Special Remediation of Medical Supplies, and started to tackle prominent problems in the production, distribution and use of medical consumables and further strengthened the rational use of medical consumables. The revised Anti-Unfair Competition Law will come into force on January 1, 2018, and will focus on various forms of commercial bribery and unfair competition.

According to the requirements of the comprehensive medical reform, on the basis of controlling the proportion of hospital medicines, consumables, examinations and laboratory tests, the average increase in the average cost of outpatients and inpatients was further reduced, of which, the expenditure on medical expenses (excluding pharmaceutical products) The material dropped below 20 yuan.

With the implementation of policies such as "two-vote system", "zero addition" and "centralized purchasing" gradually implemented in the field of medical devices and the implementation of the 'single disease payment' model, regulatory agencies such as health and family planning will continue to intensify their supervision, Medical institutions are facing increasingly serious management situation.

In order to implement the requirements of comprehensive medical reform and realize the transformation and upgrading, the medical institutions will strictly control the proportion of medical materials and save the cost of consumables. The Company will continue to optimize the product structure and adjust the supply catalogs. Some provinces and cities have started the 'second bargain' to reduce consumables prices.

Large-scale cost advantages of domestic brands will be a large number of imported, used to replace the existing expensive imported products.It is foreseeable that in order to break the monopoly of imported brands, breaking the industry barriers, the configuration and use of medical devices will usher in major changes, Domestic medical devices will enter a golden period of rapid development.

Medical institutions, as the introduction and use units of medical devices, are the "main battlefields" for the implementation of various policies.In the aspect of the introduction of medical devices, from the demand plan argumentation to the procurement review, no discriminatory and differential treatment of domestic medical devices shall be established, and the positive Implementation of fair allocation standards, and create a clear atmosphere of the procurement environment.

Public medical institutions should also implement the requirements of the "Government Procurement Law," give priority to the purchase of domestic brands.Due to the technical performance gap, domestic equipment temporarily unable to meet the clinical needs, you can apply for the designated purchase of imported brands and approval according to the regulations.At the same time, in the domestic production of foreign Brand and joint venture brand should be regarded as domestic brands.

In October 2017, the "Blue Book for China Medical Device Industry Development Report (2017)" was released, which systematically reviewed the difficult process of medical device development in our country and full of expectations for the development of medical device industry in China.

In fact, China's medical equipment industry has formed a number of medical equipment industry gathering area and manufacturing development zone, emerged in Shenzhen Mindray, Shandong Granville, Shanghai Liangyu, Beijing Lepu, Shandong Xinhua, Jiangsu diving and a number of high quality Of the national brand, they based their own traditional areas of excellence, completed a series of product layout, in the consolidation of the domestic market based on active in the international market.

At the same time, the confidence of domestic medical institutions in national brands is steadily improving, and the market prospect continues to improve.

In short, the development of medical equipment national brand is in the ascendant, but the road of development is full of twists and turns, the unbalanced development still remains to be resolved.Atomic authorities at all levels should profoundly recognize that the upgrade of domestic medical equipment configuration has become an issue of inadequate development imbalances The inevitable request.

All medical personnel should take the responsibility of boosting the development of national brands as their responsibility, grasp the trend of policies, enhance the concept of the rule of law, establish a high degree of self-confidence of national brands, actively eliminate the disadvantages of the industry, help supply-side reform, increase the quality of medical service supply, Growing health care needs.